Regional c-Fos and FosB/δFosB expression associated with chronic methamphetamine self-administration and methamphetamine-seeking behavior in rats

Neuroscience

Volumn 206, Issue , 2012, Pages 100-114

  Cornish, J L ^a   Hunt, G E ^b   Robins, L ^c,d   McGregor, I S ^c  

^a MACQUARIE UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d Department of Family and Community Services ^*  (Australia)

Author keywords

Addiction; C Fos; FosB; Methamphetamine; Orexin; Self administration

Indexed keywords

ISOPROTEIN; METHAMPHETAMINE; OREXIN; PROTEIN C FOS; SODIUM CHLORIDE; TRANSCRIPTION FACTOR FOSB;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DIAGONAL BAND OF BROCA; DORSAL RAPHE NUCLEUS; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; LATERAL HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; UPREGULATION; VENTRAL TEGMENTUM;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG-SEEKING BEHAVIOR; IMMUNOHISTOCHEMISTRY; MALE; METHAMPHETAMINE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; SELF ADMINISTRATION;

EID: 84857653369     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.01.004     Document Type: Article

References (83)

1. Aston-Jones G., Smith R.J., Moorman D.E., Richardson K.A. Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology 2009, 56(Suppl 1):112-121.
2. Beauvais G., Jayanthi S., McCoy M.T., Ladenheim B., Cadet J.L. Differential effects of methamphetamine and SCH23390 on the expression of members of IEG families of transcription factors in the rat striatum. Brain Res 2010, 1318:1-10.
3. Belcher A.M., O'Dell S.J., Marshall J.F. Long-term changes in dopamine-stimulated gene expression after single-day methamphetamine exposure. Synapse 2009, 63:403-412.
4. Botly L.C., Burton C.L., Rizos Z., Fletcher P.J. Characterization of methylphenidate self-administration and reinstatement in the rat. Psychopharmacology (Berl) 2008, 199:55-66.
5. Boutrel B., Kenny P.J., Specio S.E., Martin-Fardon R., Markou A., Koob G.F., de Lecea L. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A 2005, 102:19168-19173.
6. Cardinal R.N., Parkinson J.A., Hall J., Everitt B.J. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev 2002, 26:321-352.
7. Carson D.S., Cornish J.L., Guastella A.J., Hunt G.E., McGregor I.S. Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats. Neuropharmacology 2010, 58:38-43.
8. Carson D.S., Hunt G.E., Guastella A.J., Larber L., Cornish J.L., Arnold J.C., Boucher A.A., McGregor I.S. Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addict Biol 2010, 15:448-463.
9. Casini A., Vivacqua G., Pontieri F.E., Kimura H., Bellier J.P., D'Este L., Renda T.G. Choline acetyltransferase of the common type immunoreactivity in the rat brain following different heroin treatments: a pilot study. J Chem Neuroanat 2011, 41:111-121.
10. Chung S., Hopf F.W., Nagasaki H., Li C.Y., Belluzzi J.D., Bonci A., Civelli O. The melanin-concentrating hormone system modulates cocaine reward. Proc Natl Acad Sci U S A 2009, 106:6772-6777.
11. Clemens K.J., Cornish J.L., Hunt G.E., McGregor I.S. Repeated weekly exposure to MDMA, methamphetamine or their combination: Long-term behavioural and neurochemical effects in rats. Drug Alcohol Depend 2007, 86:183-190.
12. Cornish J.L., Clemens K.J., Thompson M.R., Callaghan P.D., Dawson B., McGregor I.S. High ambient temperature increases intravenous methamphetamine self-administration on fixed and progressive ratio schedules in rats. J Psychopharmacol 2008, 22:100-110.
13. Cruickshank C.C., Dyer K.R. A review of the clinical pharmacology of methamphetamine. Addiction 2009, 104:1085-1099.
14. Davidson C., Gow A.J., Lee T.H., Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Brain Res Rev 2001, 36:1-22.
15. Dayas C.V., McGranahan T.M., Martin-Fardon R., Weiss F. Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse. Biol Psychiatry 2008, 63:152-157.
16. Easton A., Fitchett A.E., Eacott M.J., Baxter M.G. Medial septal cholinergic neurons are necessary for context-place memory but not episodic-like memory. Hippocampus 2011, 21:1021-1027.
17. España R.A., Oleson E.B., Locke J.L., Brookshire B.R., Roberts D.C., Jones S.R. The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. Eur J Neurosci 2010, 31:336-348.
18. Estabrooke I.V., McCarthy M.T., Ko E., Chou T.C., Chemelli R.M., Yanagisawa M., Saper C.B., Scammell T.E. Fos expression in orexin neurons varies with behavioral state. J Neurosci 2001, 21:1656-1662.
19. Fadel J., Deutch A.Y. Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 2002, 111:379-387.
20. Georgescu D., Zachariou V., Barrot M., Mieda M., Willie J.T., Eisch A.J., Yanagisawa M., Nestler E.J., DiLeone R.J. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 2003, 23:3106-3111.
21. Goldstein R.Z., Volkow N.D. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci 2011, 12:652-669.
22. Golmayo L., Nuñez A., Zaborszky L. Electrophysiological evidence for the existence of a posterior cortical-prefrontal-basal forebrain circuitry in modulating sensory responses in visual and somatosensory rat cortical areas. Neuroscience 2003, 119:597-609.
23. Gray J.A. The neuropsychology of anxiety. Br J Psychol 1978, 69:417-434.
24. Gross N.B., Marshall J.F. Striatal dopamine and glutamate receptors modulate methamphetamine-induced cortical Fos expression. Neuroscience 2009, 161:1114-1125.
25. Hadlock G.C., Baucum A.J., King J.L., Horner K.A., Cook G.A., Gibb J.W., Wilkins D.G., Hanson G.R., Fleckenstein A.E. Mechanisms underlying methamphetamine-induced dopamine transporter complex formation. J Pharmacol Exp Ther 2009, 329:169-174.
26. Hahn J.D. Comparison of melanin-concentrating hormone and hypocretin/orexin peptide expression patterns in a current parceling scheme of the lateral hypothalamic zone. Neurosci Lett 2010, 468:12-17.
27. Hamlin A.S., Newby J., McNally G.P. The neural correlates and role of D1 dopamine receptors in renewal of extinguished alcohol-seeking. Neuroscience 2007, 146:525-536.
28. Hargreaves G.A., Hunt G.E., Cornish J.L., McGregor I.S. High ambient temperature increases 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")-induced Fos expression in a region-specific manner. Neuroscience 2007, 145:764-774.
29. Harris G.C., Wimmer M., Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 2005, 437:556-559.
30. Harris G.C., Wimmer M., Randall-Thompson J.F., Aston-Jones G. Lateral hypothalamic orexin neurons are critically involved in learning to associate an environment with morphine reward. Behav Brain Res 2007, 183:43-51.
31. Hope B.T. Cocaine and the AP-1 transcription factor complex. Ann N Y Acad Sci 1998, 844:1-6.
32. Hope B.T., Nye H.E., Kelz M.B., Self D.W., Iadarola M.J., Nakabeppu Y., Duman R.S., Nestler E.J. Induction of a long-lasting AP-1 complex composed of altered fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 1994, 13:1235-1244.
33. Hunt G.E., McGregor I.S. Rewarding brain stimulation induces only sparse Fos-like immunoreactivity in dopaminergic neurons. Neuroscience 1998, 83:501-515.
34. Hunt G.E., van Nieuwenhuijzen P.S., Chan-Ling T., McGregor I.S. "When an old rat smells a cat": A decline in defense-related, but not accessory olfactory, Fos expression in aged rats. Neurobiol Aging 2011, 32:737-749.
35. Jaber M., Cador M., Dumartin B., Normand E., Stinus L., Bloch B. Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons. Neuroscience 1995, 65:1041-1050.
36. Karila L., Weinstein A., Aubin H.J., Benyamina A., Reynaud M., Batki S.L. Pharmacological approaches to methamphetamine dependence: a focused review. Br J Clin Pharmacol 2010, 69:578-592.
37. Kaufling J., Veinante P., Pawlowski S.A., Freund-Mercier M.J., Barrot M. Afferents to the GABAergic tail of the ventral tegmental area in the rat. J Comp Neurol 2009, 513:597-621.
38. Kaufling J., Waltisperger E., Bourdy R., Valera A., Veinante P., Freund-Mercier M.J., Barrot M. Pharmacological recruitment of the GABAergic tail of the ventral tegmental area by acute drug exposure. Br J Pharmacol 2010, 161:1677-1691.
39. Kawashima N., Funakoshi T., Omura T., Chaki S., Kameo K., Okuyama S. Neuropharmacological profiles of a novel atypical antipsychotic, NRA0562, in rats. Eur J Pharmacol 2001, 423:27-33.
40. Kennerley S.W., Behrens T.E.J., Wallis J.D. Double dissociation of value computations in orbital frontal and anterior cingulate neurons. Nat Neurosci 2011, 14:1581-1589.
41. Kitanaka J., Kitanaka N., Takemura M. Neurochemical consequences of dysphoric state during amphetamine withdrawal in animal models: a review. Neurochem Res 2008, 33:204-219.
42. Konradi C., Leveque J.C., Hyman S.E. Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J Neurosci 1996, 16:4231-4239.
43. Krasnova I.N., Justinova Z., Ladenheim B., Jayanthi S., McCoy M.T., Barnes C., Warner J.E., Goldberg S.R., Cadet J.L. Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat. PLoS One 2010, 5:e8790.
44. Larson E.B., Akkentli F., Edwards S., Graham D.L., Simmons D.L., Alibhai I.N., Nestler E.J., Self D.W. Striatal regulation of δDFosB, FosB, and cFos during cocaine self-administration and withdrawal. J Neurochem 2010, 115:112-122.
45. Lawrence A.J., Cowen M.S., Yang H.J., Chen F., Oldfield B. The orexin system regulates alcohol-seeking in rats. Br J Pharmacol 2006, 148:752-759.
46. Le Jeune F., Vérin M., N'Diaye K., Drapier D., Leray E., Du Montcel S.T., Baup N., Pelissolo A., Polosan M., Mallet L., Yelnik J., Devaux B., Fontaine D., Chereau I., Bourguignon A., Peron J., Sauleau P., Raoul S., Garin E., Krebs M.O., Jaafari N., Millet B. Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography study. Biol Psychiatry 2010, 68:1016-1022. French Stimulation dans le trouble obsessionnel compulsif (STOC) study group.
47. Lee Y., Hamamura T., Ohashi K., Miki M., Fujiwara Y., Kuroda S. Carbamazepine suppresses methamphetamine-induced Fos expression in a regionally specific manner in the rat brain. Possible neural substrates responsible for antimanic effects of mood stabilizers. Neuropsychopharmacology 2000, 22:530-537.
48. Liu C.H., Ren J.Q., Yang J., Liu C.M., Mandeville J.B., Rosen B.R., Bhide P.G., Yanagawa Y., Liu P.K. DNA-based MRI probes for specific detection of chronic exposure to amphetamine in living brains. J Neurosci 2009, 29:10663-10670.
49. Mathai A., Smith Y. The corticostriatal and corticosubthalamic pathways: two entries, one target. So what?. Front Syst Neurosci 2011, 5:64.
50. McCoy M.T., Jayanthi S., Wulu J.A., Beauvais G., Ladenheim B., Martin T.A., Krasnova I.N., Hodges A.B., Cadet J.L. Chronic methamphetamine exposure suppresses the striatal expression of members of multiple families of immediate early genes (IEGs) in the rat: normalization by an acute methamphetamine injection. Psychopharmacology (Berl) 2011, 215:353-365.
51. McDaid J., Graham M.P., Napier T.C. Methamphetamine-induced sensitization differentially alters pCREB and DeltaFosB throughout the limbic circuit of the mammalian brain. Mol Pharmacol 2006, 70:2064-2074.
52. Meredith C.W., Jaffe C., Ang-Lee K., Saxon A.J. Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry 2005, 13:141-154.
53. Miyazaki K., Miyazaki K.W., Doya K. Activation of dorsal raphe serotonin neurons underlies waiting for delayed rewards. J Neurosci 2011, 31:469-479.
54. Mongeau R., Miller G.A., Chiang E., Anderson D.J. Neural correlates of competing fear behaviors evoked by an innately aversive stimulus. J Neurosci 2003, 23:3855-3868.
55. Motbey CP, Hunt GE, Bowen M, Artiss S, McGregor IS (in press) Mephedrone (4-Methylmethcathinone, "Meow"): Acute behavioural effects and distribution of Fos expression in adolescent rats. Addict Biol, in press.
56. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M., Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res 1999, 827:243-260.
57. Neisewander J.L., Baker D.A., Fuchs R.A., Tran-Nguyen L.T., Palmer A., Marshall J.F. Fos protein expression and cocaine-seeking behavior in rats after exposure to a cocaine self-administration environment. J Neurosci 2000, 20:798-805.
58. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2001, 2:119-128.
59. Nestler E.J. Transcriptional mechanisms of addiction: role of DFosB. Philos Trans R Soc B 2008, 363:3245-3255.
60. Nestler E.J., Barrot M., Self D.W. DeltaFosB: a sustained molecular switch for addiction. Proc Natl Acad Sci U S A 2001, 98:11042-11046.
61. Norwood C.S., Cornish J.L., Mallet P.E., McGregor I.S. Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats. Eur J Pharmacol 2003, 465:105-114.
62. Paxinos G., Watson C. The Rat brain in stereotaxic coordinates 1997, Academic Press, Sydney. compact 3rd ed.
63. Perrotti L.I., Bolaños C.A., Choi K.H., Russo S.J., Edwards S., Ulery P.G., Wallace D.L., Self D.W., Nestler E.J., Barrot M. DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment. Eur J Neurosci 2005, 21:2817-2824.
64. Perrotti L.I., Weaver R.R., Robison B., Renthal W., Maze I., Yazdani S., Elmore R.G., Knapp D.J., Selley D.E., Martin B.R., Sim-Selley L., Bachtell R.K., Self D.W., Nestler E.J. Distinct patterns of DeltaFosB induction in brain by drugs of abuse. Synapse 2008, 62:358-369.
65. Pontieri F.E., Crane A.M., Seiden L.S., Kleven M.S., Porrino L.J. Metabolic mapping of the effects of intravenous methamphetamine administration in freely moving rats. Psychopharmacology (Berl) 1990, 102:175-182.
66. Reichel C.M., See R.E. Modafinil effects on reinstatement of methamphetamine seeking in a rat model of relapse. Psychopharmacology (Berl) 2010, 210:337-346.
67. Renthal W., Carle T.L., Maze I., Covington H.E., Truong H.T., Alibhai I., Kumar A., Montgomery R.L., Olson E.N., Nestler E.J. DeltaFosB mediates epigenetic desensitization of the c-fos gene after chronic amphetamine exposure. J Neurosci 2008, 28:7344-7349.
68. Rothman R.B., Baumann M.H. Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 2003, 479:23-40.
69. Rotllant D., Márquez C., Nadal R., Armario A. The brain pattern of c-fos induction by two doses of amphetamine suggests different brain processing pathways and minor contribution of behavioural traits. Neuroscience 2010, 168:691-705.
70. Rouaud T., Lardeux S., Panayotis N., Paleressompoulle D., Cador M., Baunez C. Reducing the desire for cocaine with subthalamic nucleus deep brain stimulation. Proc Natl Acad Sci U S A 2010, 107:1196-1200.
71. Schwendt M., Rocha A., See R.E., Pacchioni A.M., McGinty J.F., Kalivas P.W. Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. J Pharmacol Exp Ther 2009, 331:555-562.
72. Sekine Y., Ouchi Y., Sugihara G., Takei N., Yoshikawa E., Nakamura K., Iwata Y., Tsuchiya K.J., Suda S., Suzuki K., Kawai M., Takebayashi K., Yamamoto S., Matsuzaki H., Ueki T., Mori N., Gold M.S., Cadet J.L. Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci 2008, 28:5756-5761.
73. Semba J., Tanaka N., Wakuta M., Suhara T. Neonatal phencyclidine treatment selectively attenuates mesolimbic dopamine function in adult rats as revealed by methamphetamine-induced behavior and c-fos mRNA expression in the brain. Synapse 2001, 40:11-18.
74. Shilling P.D., Kuczenski R., Segal D.S., Barrett T.B., Kelsoe J.R. Differential regulation of immediate-early gene expression in the prefrontal cortex of rats with a high vs low behavioral response to methamphetamine. Neuropsychopharmacology 2006, 31:2359-2367.
75. Staples L.G., McGregor I.S., Hunt G.E. Long-lasting FosB/DeltaFosB mmunoreactivity in the rat brain after repeated cat odor exposure. Neurosci Lett 2009, 462:157-161.
76. Thiriet N., Zwiller J., Ali S.F. Induction of the immediate early genes egr-1 and c-fos by methamphetamine in mouse brain. Brain Res 2001, 919:31-40.
77. Topple A.N., McGregor I.S., Hunt G.E. Possible neural substrates of beer-craving in rats. Neurosci Lett 1998, 252:99-102.
78. Torres G., Rivier C. Differential effects of intermittent or continuous exposure to cocaine on the hypothalamic-pituitary-adrenal axis and c-fos expression. Brain Res 1992, 571:204-211.
79. van Nieuwenhuijzen P.S., McGregor I.S., Hunt G.E. The distribution of gamma-hydroxybutyrate-induced Fos expression in rat brain: comparison with baclofen. Neuroscience 2009, 158:441-455.
80. Winstanley C.A., Bachtell R.K., Theobald D.E., Laali S., Green T.A., Kumar A., Chakravarty S., Self D.W., Nestler E.J. Increased impulsivity during withdrawal from cocaine self-administration: role for DeltaFosB in the orbitofrontal cortex. Cereb Cortex 2009, 19:435-444.
81. Zahm D.S., Becker M.L., Freiman A.J., Strauch S., Degarmo B., Geisler S., Meredith G.E., Marinelli M. Fos after single and repeated self-administration of cocaine and saline in the rat: emphasis on the basal forebrain and recalibration of expression. Neuropsychopharmacology 2010, 35:445-463.
82. Zhang Y., Loonam T.M., Noailles P.A., Angulo J.A. Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Ann N Y Acad Sci 2001, 937:93-120.
83. Zhou Y., Cui C.L., Schlussman S.D., Choi J.C., Ho A., Han J.S., Kreek M.J. Effects of cocaine place conditioning, chronic escalating-dose "binge" pattern cocaine administration and acute withdrawal on orexin/hypocretin and preprodynorphin gene expressions in lateral hypothalamus of Fischer and Sprague-Dawley rats. Neuroscience 2008, 153:1225-1234.